Esperion Therapeutics, Inc. (ESPR)
3.48
-0.04
(-1.14%)
USD |
NASDAQ |
Feb 20, 16:00
3.48
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Market Cap : 831.94M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 1.276B |
| Rigel Pharmaceuticals, Inc. | 643.65M |
| AnaptysBio, Inc. | 1.500B |
| ACADIA Pharmaceuticals, Inc. | 4.059B |
| Alnylam Pharmaceuticals, Inc. | 44.59B |
Market Cap Related Metrics
| PS Ratio | 2.262 |
| Price | 3.48 |
| Earnings Yield | -15.40% |